Latest Boardroom Shifts News

Tolu Minerals has appointed Dr Chris Muller as Managing Director and CEO, signaling a strategic push towards ramped-up exploration and resource development in Papua New Guinea.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

Integral Diagnostics has appointed Jason Martinez as its new CEO, set to lead the company’s growth and innovation efforts starting in 2026. Martinez brings over two decades of diagnostic imaging leadership experience, promising a strategic focus on expansion and operational excellence.

Iress launches a comprehensive FY26 business efficiency program targeting a 25% cash EBITDA margin, while narrowing its FY25 guidance and welcoming a new CEO.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Seven West Media reports a 6% EBITDA rise in H2 FY25 driven by TV and digital growth, while announcing a transformative merger with Southern Cross Media.

Dr Andrew Blattman, who has led IPH Limited through nearly a decade of transformative growth and international expansion, will retire as CEO in the second half of 2026. The Board has initiated a search for his successor to ensure a smooth leadership transition.